Sex: U
Vaccine: RAB
Symptoms: Inappropriate schedule of product administration, Overdose
Clinical narrative: In the past year patient received 14 doses of RabAvert vaccine; In the past year patient received 14 doses of RabAvert vaccine; Case reference number US-BN-2023-001385 is a spontaneous case report initially received from other health care professional (medical assistant) via Agency (reference number: USBAV23-1195) on 11-Aug-2023 and concerns a patient of unspecified age and gender.  The patient's relevant medical history and concomitant medication details were not provided.  On an unspecified date, (reported as in the past year) the patient was vaccinated with the 14 doses of RabAvert vaccine (batch number: unknown) at an unknown dose, intramuscularly, at unknown site of administration, for indication reported as potential exposure to rabies. As reported initial administration consisted of four doses, followed by two rounds of two doses each, and then another four doses, additional two doses were administered one month ago (explicitly coded as 'overdose' and 'inappropriate schedule of vaccine administered')  As reported, patient suspected a new exposure to a bat and requires two more doses.  At the time of the initial report, it was unknown if the patient experienced any adverse event due to RabAvert vaccination.  Additional information received from Agency on 14-Aug-2023 included local Agency case ID.; Reporter's Comments: A patient of unspecified age and gender was vaccinated with the 14 doses of RabAvert vaccine for indication reported as potential exposure to rabies. As reported initial administration consisted of four doses, followed by two rounds of two doses each, and then another four doses, additional two doses were administered one month ago, which is considered as overdose and inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse event due to RabAvert vaccination. Overdose and inappropriate schedule of vaccine administered are considered as listed per company convention. The patient's relevant medical history and concomitant medication details were not provided. Overdose and inappropriate schedule of vaccine administered have been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A patient of unspecified age and gender was vaccinated with the 14 doses of RabAvert vaccine for indication reported as potential exposure to rabies. As reported initial administration consisted of four doses, followed by two rounds of two doses each, and then another four doses, additional two doses were administered one month ago, which is considered as overdose and inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse event due to RabAvert vaccination. Overdose and inappropriate schedule of vaccine administered are considered as listed per company convention. The patient's relevant medical history and concomitant medication details were not provided. Overdose and inappropriate schedule of vaccine administered have been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.